Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / JAMA
Entity

JAMA

Tracked across 1 events · 93 articles · First seen Jul 16, 2026 · Last active Aug 04, 2026

Sentiment
0
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
6 0
Regulatory
FDA approves Merck's Lipfendra cholesterol pill
Impact: Published one of the phase 3 trial results; provides scientific credibility.
Jul 16, 2026 · 93 articles
ERGEN INTELLIGENCE
Track JAMA live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.